高级检索

我国药品创新发展趋势分析与建议

Analysis and suggestions on the development trend of drug innovation in China

  • 摘要: 为了充分评估我国在全球药品创新所处阶段,进一步优化我国药品创新环境,释放药品创新活力,本文从全球药品研发创新市场现状、研发投入、产品管线、政策支持以及发展趋势等角度,结合我国药品创新发展的特点,着重比较分析我国药品创新的全球竞争状况,发现我国药品创新存在着创新发展阶段落后于发达国家、扎堆研发竞争、突击式的研发冒进、药品创新过度依赖资本市场等现实问题,针对性提出持续改善中国新药创新环境、理性选择差异化竞争与新赛道、合理制定药品创新发展策略、引导资本回归创新研发本质以及构建药品创新“双循环”战略等建议。

     

    Abstract: In order to comprehensivehy evaluate the stage of China in the global drug innovation, to further optimize the environment for drug innovation in China, and to unleash the vitality of drug innovation, this article mainly analyzes through comparison China''s situation of drug innovation in global competition from such perspectives as the current situation of the global drug R&D innovation market, R&D investment, product pipeline, policy support, and development trends, combined with the characteristics of China''s drug innovation development.It can be seen that China''s pharmaceutical innovation is faced with such practical problems as lagging behind some developed countries in terms of innovation development, companies bunching into research and development innovation, sudden research and development rush, and excessive dependence on capital markets for pharmaceutical innovation.Accordingly, this paper puts forward suggestions on continuously improving China''s new drug innovation environment, rationally selecting differentiated competition and new tracks, reasonably formulating drug innovation development strategies, guiding capital to return to innovative research and development, and constructing a "double cycle" strategy for drug innovation.

     

/

返回文章
返回